Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$26.42 – $63.29
10% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.28B | $1.46B | $1.34B | $1.65B | $1.90B | $2.09B | $2.07B | $2.23B |
| Cost of revenue | $570.5M | $627.4M | $589.9M | $679.6M | $775.2M | $883.5M | $977.5M | $1.05B |
| Gross profit | $710.4M | $831.9M | $745.5M | $967.2M | $1.13B | $1.21B | $1.09B | $1.18B |
| Gross margin | 55.5% | 57.0% | 55.8% | 58.7% | 59.3% | 57.7% | 52.7% | 52.8% |
| R&D | $159.6M | $173.3M | $218.8M | $232.1M | $291.4M | $349.3M | $343.1M | $326.3M |
| Operating income | $197.1M | $252.5M | $159.3M | $350.9M | $396.9M | $327.1M | $121.4M | $223.3M |
| EBITDA | $213.1M | $286.4M | $267.0M | $410.0M | $482.9M | $501.9M | $225.1M | $407.0M |
| Net income | $126.5M | $159.8M | $122.4M | $236.3M | $293.9M | $290.4M | $178.7M | $141.2M |
| Net margin | 9.9% | 10.9% | 9.2% | 14.3% | 15.4% | 13.9% | 8.7% | 6.3% |
| EPS (diluted) | 1.41 | 1.79 | 1.37 | 2.64 | 3.29 | 3.25 | 2.01 | 1.61 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.2B | $1.32 | $1.28–$1.42 | 9 |
| 2027 | $2.3B | $1.67 | $1.62–$1.80 | 5 |
| 2028 | $2.4B | $2.08 | $2.01–$2.25 | 6 |
| 2029 | $2.6B | $2.77 | $2.69–$3.00 | 9 |
Forward consensus · source: Financial Modeling Prep
CARL ZEISS MEDITEC AG
No one on the platform currently holds CZMWF.
No tracked institution reports a position in CZMWF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-30 | $0.5500 | 2026-03-31 |
| 2025-03-28 | $0.6000 | 2025-03-31 |
| 2024-03-22 | $1.1000 | 2024-03-25 |
No one on the platform has traded CZMWF yet.
| +0.00% |
| $4.3B |
| — |
| FLMNFFielmann AG | $50.75 | +0.00% | $4.3B | — |
| FLMNYFielmann Group AG | $9.94 | +0.00% | $4.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 17.0× earnings vs its 38.4× historical median P/E.
Fair value ≈ $67.51 · price $30.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.